The effect of an intramuscular injection of pentobarbitone 2 mg/kg on the hypoxic ventilatory drive was measured in 10 volunteers. Five subjects showed significant depression of the ventilatory response to hypoxia 30 min after administration. This depression persisted for 90 min. The other five subjects showed no change from control responses. The two groups appeared to differ in their levels of physical fitness as measured by differences in resting heart rate and maximal oxygen uptake.
respiratory valve (Collins) from which end-tidal oxygen and carbon dioxide were sampled continuously by a fuel-cell oxygen analyser (Sodal, Bowman and Filley, 1968) and an infra-red carbon dioxide analyser (Beckman LB-1) respectively. It was assumed that the concentrations of end-tidal gases were equal to those of alveolar gases. The output from both analysers, together with information from a pneumotachograph (Fleisch) were fed into an on-line PDP-8 computer; the data emerged as continuous, real-time oscilloscope plots of end-tidal oxygen partial pressure, carbon dioxide partial pressure, and minute ventilation. Initially, the subjects breathed oxygen 40% to which nitrogen was added to produce a reduction in PA 02 from 120 to 40 mm Hg over a period of 15-20 min. The output from the carbon dioxide analyser was also displayed on an oscilloscope and used to guide the manual addition of carbon dioxide 100% to the inspired gas in amounts sufficient to prevent hypocapnia. The accuracy of maintaining normocapnia and a stable pH by this method has been confirmed by simultaneous arterial blood analysis (Weil et al., 1970) .
The plots of ventilation against PA O2 are hyperbolic ( fig. 1 ). In order to compare curves the following equation is used (Weil et al., 1970) , relating ventilation to alveolar Po 2 :
VE=VEO+A/(PAO 2 -32) where VE is minute ventilation in litre/min BTPS and PAO 2 is alveolar Po 2 in mm Hg. VEO is the value for ventilation extrapolated to an infinitely large PA02 (x asymptote). Thirty-two is the y asymptote. The parameter A describes the shape of the curve such that the higher the value for A the greater the ventilatory response to hypoxia. The curve-fitting procedure and evaluation of parameters is computed by a least-squares regression plot of VE against PAO 2 -Two control hypoxic drive studies were performed on each subject, following which pentobarbitone 2 mg/kg was administered i.m. Measurements of the ventilatory responses to hypoxia were made 30,45, 60 and 75 min, and in some instances 105 min after injection. Resting ventilation was calculated as VE at a PA 02 of 120 mm Hg from the subject's A value. The drug used consisted of pentobarbitone 50 mg/ml in propyleneglycol 40% and alcohol 10%.
Maximal oxygen uptake was measured by a modified Balke test. With the treadmill set at 5.6 k.p.h., the subject walked for 10 min at this rate. Then the treadmill speed was increased to 11.3 k.p.h. and the subject ran at this predetermined rate. At subsequent 2-min intervals, the treadmill speed was increased by 2%. The test continued until the subject signalled his inability to continue. Expired gas was collected in bags during the last 30 sec of each 2-min work-load and gas samples were analysed by gas chromatography.
Statistical analysis was carried out using paired and unpaired t tests (Dixon and Massey, 1969) .
RESULTS
Details of the subjects studied are shown in table I. Approximately 30 min after the pentobarbitone injection all 10 subjects exhibited drowsiness which lasted 105-120 min. Resting ventilation and end-tidal carbon dioxide partial pressures were unaffected by the drug (table II) . It should be noted that resting ventilation was not measured, but was calculated from the curve and this may explain changes in resting ventilation without a measured change in PA C O 2 -The normal resting arterial carbon dioxide tension in Denver (altitude 1600 m) is 35.6±0.57 mm Hg (mean+SEM) (Weil et al., 1968) and the normal (Hirshman, McCullough and Weil, 1975) . Hypoxic ventilatory drive was not significantly affected in the group as a whole. In examining the individual results, it was noted that the ventilatory response to hypoxia was depressed by pentobarbitone in five subjects (30-50% depression) and unchanged in the other five (table  III; figs. 2 and 3) . Within the group showing depression of this response, changes were observed first at 30 min and were maximal at 60 min. In all but one subject, the ventilatory response to hypoxia had returned to normal by 120 min, as shown in figure 3. It is possible that our subjects may comprise two separate subgroups. However, the ages, weights, resting ventilation and PA C 02 wer e not significantly different in the two groups, but there were three females and two males in the group with a depressed ventilatory response and five males in the nondepressed group. On the other hand, the subjects with the five lowest maximal oxygen uptake values showed obvious depression of A, while those with the highest maximum oxygen uptake showed no such depression. Furthermore, resting heart rates were lower (58±3 v. 71±5 beats/min; P<0.05) in the group that showed no change in hypoxic ventilatory drive. The difference in hypoxic ventilatory drive between these two groups is summarized in table IV.
DISCUSSION
In healthy subjects, pentobarbitone, in amounts commonly used to produce mild sedation, had no effect on resting ventilation and resting PA C 02 but depressed the ventilatory response to hypoxia in 50% of our subjects. The absence of alterations in resting ventilation is in agreement with the findings of Stephen and colleagues (1970) , who observed no hypoventilation with a comparable dose of secobarbitone. Keats and Kurosu (1957) found an increase in ventilation after pentobarbitone 1.4 mg/kg but a decrease following 2.8 mg/kg. In our study, evidence for a respiratory effect of pentobarbitone comprises a depression of the ventilatory response to hypoxia in five of our subjects and no change in the response in the remaining five.
There have been few previous investigations of the effects of the barbiturates on the ventilatory response to hypoxia. Harris and Slawson (1965) demonstrated in three subjects that three times the conventional dose of cyclobarbitone resulted in some depression of ventilation during hypoxia. However, only very mild Downloaded from https://academic.oup.com/bja/article-abstract/47/9/963/263397 by guest on 05 December 2018 hypoxia was employed (PAO 2 =60 mm Hg), which is insufficient to produce a well-developed hypoxic response in normal man (Weil et al., 1970) .
In 50% of our subjects, there was no depression of the hypoxic ventilatory drive with pentobarbitone so there would appear to be two populations which differ with respect to the effect of pentobarbitone on the ventilatory response to hypoxia. These subgroups also differ in their level of physical conditioning as measured by maximal oxygen uptake and resting heart rate. Those subjects whose ventilatory response to hypoxia was unaffected by pentobarbitone and who were involved in athletic activities on a regular basis had lower resting heart rates and higher maximal oxygen uptake than the subjects in the group which exhibited depression of the ventilatory response to hypoxia. Bryne-Quinn and colleagues (1971) found that true athletes have a marked decrease in ventilatory response to both hypoxia and hypercapnia at rest. While we found no significant difference in control levels of the ventilatory response to hypoxia between the two groups, some other factor distinguishing athletes from non-athletes could account for the differences in response to the drug. Body weight was similar in the two groups and the drug was administered on a weight basis. However, it is possible that differences in lean body mass or in drug metabolism or redistribution could account for this difference. Unfortunately, we did not measure the blood con-. centrations of barbiturates in any of our subjects and so cannot exclude the possibility that differences in drug metabolism may have contributed to the different effects in the two groups. Our study was not designed on a double-blind basis as we believed that our subjects would have been able to distinguish the difference between pentobarbitone and a placebo.
This study suggests that sedentary, less physically fit individuals are more likely to exhibit depression of the ventilatory response to hypoxia when pentobarbitone is administered. Whether or not a larger dose of barbiturates will result in depression of this response in more physically fit individuals still remains to be answered. It is suggested that drug dosage should be related to maximal oxygen uptake rather than body weight in order to bring all individuals onto the same dose-response curve. 
